ASCO25 GI Malignancies: Key Updates With Dr Loaiza-Bonilla
In this video, Dr. Loaiza-Bonilla shares his expert insights on:-MATTERHORN Trial (Gastric/GEJ Adenocarcinoma): Understanding the implications of perioperati…
In this video, Dr. Loaiza-Bonilla shares his expert insights on:-MATTERHORN Trial (Gastric/GEJ Adenocarcinoma): Understanding the implications of perioperati…
A promising clinical trial shows that a combination of paxalisib, pembrolizumab, and chemotherapy significantly reduces circulating tumor cells in metastatic triple-negative breast cancer.
An expert discusses how the treatment landscape for lower-risk MDS has evolved with multiple new options including luspatercept, imetelstat, and lenalidomide based on specific patient…
What happens on Match Day? How many residency programs are there in the US? How many medical students matched in 2025? What happens if you…
During a live event, Jeffrey V. Matous, MD, discussed bispecific antibody treatment efficacy and safety in advanced multiple myeloma.
IAS 2025, the 13th IAS Conference on HIV Science, will highlight the latest science, innovation and frontline efforts in addressing HIV on the African contin…
New research reveals that combining lurbinectedin with atezolizumab significantly improves survival rates for patients with extensive-stage small cell lung cancer.
Anita Turk, MD, discusses what she is most excited about regarding immunotherapy in the realm of colorectal cancer treatment.
Someone skipped this economics class.Stream the classic Ferris Bueller’s Day Off now on BINGE.#FerrisBuellersDayOff #FerrisBueller #Economics #Tariff #Tariff…
Join, follow and share ARUTZ SHEVA:✉️ Newsletter: https://www.israelnationalnews.com/more/newsletter🤳🏻X (Twitter): https://twitter.com/ArutzSheva_En📷 Inst…